Exodus Point Capital Management, LP Abb Vie Inc. Call Options Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$163.84 - $199.33 $3.13 Million - $3.81 Million
-19,100 Reduced 92.27%
1,600 $316,000
Q2 2024

Aug 13, 2024
BUY
$154.79 - $180.76 $696,555 - $813,420
4,500 Added 27.78%
20,700 $3.55 Million
Q1 2024

May 14, 2024
BUY
$159.82 - $182.1 $2.59 Million - $2.95 Million
16,200 New
16,200 $2.95 Million

Others Institutions Holding ABBV

# of Institutions
3,852
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email